Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.
暂无分享,去创建一个
Sanjeev Chawla | Harry Quon | Harish Poptani | S. Chawla | H. Quon | S. Kim | L. Loevner | Harish Poptani | E. Sherman | Sungheon Kim | Laurie A Loevner | Eric Sherman | Su Berrak | S. Berrak | Su G Berrak
[1] H. Thames,et al. Tumor volume: a basic and specific response predictor in radiotherapy. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] T. Bezabeh,et al. Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. , 2005, AJNR. American journal of neuroradiology.
[3] U. Sharma,et al. Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy , 2009, NMR in biomedicine.
[4] G. Weinstein,et al. Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck , 2009, Clinical Cancer Research.
[5] B. Fallone,et al. Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model , 2010, Physics in medicine and biology.
[6] R. Hermans,et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma , 2010, European Radiology.
[7] T. Cloughesy,et al. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma , 1999, Magnetic resonance in medicine.
[8] A. Razek,et al. Role of Diffusion-Weighted Echo-Planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes , 2007, American Journal of Neuroradiology.
[9] G. Calais,et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] T. Chenevert,et al. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. , 2008, Translational oncology.
[11] T. Wendt,et al. Prognostic Factors in Squamous Cell Carcinoma of the Head and Neck , 2002, Oncology Research and Treatment.
[12] V. Devita,et al. Cancer : Principles and Practice of Oncology , 1982 .
[13] Ruth C Carlos,et al. Computed Tomography Perfusion of Squamous Cell Carcinoma of the Upper Aerodigestive Tract: Initial Results , 2003, Journal of computer assisted tomography.
[14] D J Brenner,et al. Dose, volume, and tumor-control predictions in radiotherapy. , 1993, International journal of radiation oncology, biology, physics.
[15] B. Fallone,et al. Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy. , 2009, Medical physics.
[16] Tim Baker,et al. Economic burden of heart failure: a summary of recent literature. , 2004, Heart & lung : the journal of critical care.
[17] K. Hayashi,et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. , 2003, AJNR. American journal of neuroradiology.
[18] K. Ang,et al. Head and Neck Cancers , 2011 .
[19] K. Frey,et al. Advanced squamous cell carcinoma of the oropharynx: Efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy , 2009, Head & neck.
[20] F. Hoebers,et al. Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer , 2010, Head & neck.
[21] M. Kanematsu,et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect , 2008, European Radiology.
[22] S. Takashima,et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. , 2001, Radiology.
[23] H. Minn,et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] À. Rovira,et al. 31Phosphorus magnetic resonance spectroscopy in the assessment of head and neck tumors. , 1998, International journal of radiation oncology, biology, physics.
[25] J. Jacobs,et al. Correlation between response to cisplatinum‐combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck , 1984, Cancer.
[26] S. Mukherji,et al. Differentiation of Benign and Malignant Pathology in the Head and Neck Using 3T Apparent Diffusion Coefficient Values: Early Experience , 2008, American Journal of Neuroradiology.
[27] A. Ruifrok,et al. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] Risto A Kauppinen,et al. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.
[29] James M Provenzale,et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.
[30] J. Vermorken,et al. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited? , 2007, Cancer letters.
[31] G. Weinstein,et al. Prediction of Response to Chemoradiation Therapy in Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging , 2010, American Journal of Neuroradiology.
[32] Ann D. King,et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response , 2010, European Radiology.
[33] J. Vermorken,et al. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. , 2008, Seminars in oncology.
[34] Mark Rijpkema,et al. Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. , 2002, Academic radiology.
[35] M. Fury,et al. Induction chemotherapy in the management of head and neck cancer , 2010, Journal of surgical oncology.
[36] R. Bast,et al. Principles of Medical Oncology , 2003 .
[37] T L Chenevert,et al. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] R. Gillies,et al. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.
[39] Sandra Nuyts,et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.
[40] J. Pipe,et al. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. , 1996, British Journal of Cancer.
[41] M. Leblanc,et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. , 2004, Archives of otolaryngology--head & neck surgery.
[42] A. Garden,et al. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? , 2004, Cancer.
[43] Philippe Lambin,et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[44] J. Griffiths,et al. The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy. , 2006, Neoplasia.
[45] A. Razek,et al. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors , 2008, Acta radiologica.
[46] R. Kauppinen,et al. Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. , 1998, Cancer gene therapy.
[47] K. Kihara,et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. , 2010, Urology.